These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17928361)

  • 41. Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates FcγR1 and FcγR2B on murine microglia.
    Rissiek B; Menzel S; Leutert M; Cordes M; Behr S; Jank L; Ludewig P; Gelderblom M; Rissiek A; Adriouch S; Haag F; Hottiger MO; Koch-Nolte F; Magnus T
    Sci Rep; 2017 Nov; 7(1):16477. PubMed ID: 29184112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Methodological Approach Using rAAV Vectors Encoding Nanobody-Based Biologics to Evaluate ARTC2.2 and P2X7
    Gondé H; Demeules M; Hardet R; Scarpitta A; Junge M; Pinto-Espinoza C; Varin R; Koch-Nolte F; Boyer O; Adriouch S
    Front Immunol; 2021; 12():704408. PubMed ID: 34489954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. P2X7 on Mouse T Cells: One Channel, Many Functions.
    Rissiek B; Haag F; Boyer O; Koch-Nolte F; Adriouch S
    Front Immunol; 2015; 6():204. PubMed ID: 26042119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Basal and inducible expression of the thiol-sensitive ART2.1 ecto-ADP-ribosyltransferase in myeloid and lymphoid leukocytes.
    Hong S; Brass A; Seman M; Haag F; Koch-Nolte F; Dubyak GR
    Purinergic Signal; 2009 Sep; 5(3):369-83. PubMed ID: 19404775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of ligands for ADP-ribosyltransferases via docking-based virtual screening.
    Andersson CD; Karlberg T; Ekblad T; Lindgren AE; Thorsell AG; Spjut S; Uciechowska U; Niemiec MS; Wittung-Stafshede P; Weigelt J; Elofsson M; Schüler H; Linusson A
    J Med Chem; 2012 Sep; 55(17):7706-18. PubMed ID: 22823910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The P2X7 Receptor.
    Sluyter R
    Adv Exp Med Biol; 2017; 1051():17-53. PubMed ID: 28676924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice.
    Ohlrogge W; Haag F; Löhler J; Seman M; Littman DR; Killeen N; Koch-Nolte F
    Mol Cell Biol; 2002 Nov; 22(21):7535-42. PubMed ID: 12370300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure of mouse ADP-ribosylhydrolase 3 (mARH3).
    Mueller-Dieckmann C; Kernstock S; Mueller-Dieckmann J; Weiss MS; Koch-Nolte F
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Mar; 64(Pt 3):156-62. PubMed ID: 18323597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blocking the ART2.2/P2X7-system is essential to avoid a detrimental bias in functional CD4 T cell studies.
    Georgiev H; Ravens I; Papadogianni G; Malissen B; Förster R; Bernhardt G
    Eur J Immunol; 2018 Jun; 48(6):1078-1081. PubMed ID: 29508376
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Rissiek B; Lukowiak M; Raczkowski F; Magnus T; Mittrücker HW; Koch-Nolte F
    Front Immunol; 2018; 9():1580. PubMed ID: 30038627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conformational changes during human P2X7 receptor activation examined by structural modelling and cysteine-based cross-linking studies.
    Caseley EA; Muench SP; Jiang LH
    Purinergic Signal; 2017 Mar; 13(1):135-141. PubMed ID: 28025718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and stability analysis of potential ADP-ribose modification sites on vascular endothelial growth factor (VEGF) through molecular dynamics simulation.
    Sreelakshmi K; Hemavathi KN; Raju R; Sameer KVB; Keshava Prasad TS; Sudhakaran PR; Abhinand CS
    J Biomol Struct Dyn; 2023 Dec; ():1-9. PubMed ID: 38147402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracellular NAD and ATP: Partners in immune cell modulation.
    Haag F; Adriouch S; Braß A; Jung C; Möller S; Scheuplein F; Bannas P; Seman M; Koch-Nolte F
    Purinergic Signal; 2007 Mar; 3(1-2):71-81. PubMed ID: 18404420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Astrocytes and Microglia Are Resistant to NAD
    Rissiek B; Stabernack J; Cordes M; Duan Y; Behr S; Menzel S; Magnus T; Koch-Nolte F
    Front Mol Neurosci; 2019; 12():330. PubMed ID: 32009900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural and Functional Consequences Induced by Post-Translational Modifications in α-Defensins.
    Balducci E; Bonucci A; Picchianti M; Pogni R; Talluri E
    Int J Pept; 2011; 2011():594723. PubMed ID: 21904558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel predicted ADP-ribosyltransferase-like family conserved in eukaryotic evolution.
    Wyżewski Z; Gradowski M; Krysińska M; Dudkiewicz M; Pawłowski K
    PeerJ; 2021; 9():e11051. PubMed ID: 33854844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post-translational modifications: ADP-ribosylation promotes transcription elongation.
    Zlotorynski E
    Nat Rev Mol Cell Biol; 2016 Jun; 17(7):397. PubMed ID: 27329964
    [No Abstract]   [Full Text] [Related]  

  • 58. ADP-ribosylation of P2X7: a matter of life and death for regulatory T cells and natural killer T cells.
    Rissiek B; Haag F; Boyer O; Koch-Nolte F; Adriouch S
    Curr Top Microbiol Immunol; 2015; 384():107-26. PubMed ID: 25048544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders.
    Liu X; Li Y; Huang L; Kuang Y; Wu X; Ma X; Zhao B; Lan J
    Front Pharmacol; 2024; 15():1450704. PubMed ID: 39139642
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumour immune escape via P2X7 receptor signalling.
    Sainz RM; Rodriguez-Quintero JH; Maldifassi MC; Stiles BM; Wennerberg E
    Front Immunol; 2023; 14():1287310. PubMed ID: 38022596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.